MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis
NASDAQ:MDLZ - Nasdaq - US6092071058 - Common Stock
Overall MDLZ gets a fundamental rating of 5 out of 10. We evaluated MDLZ against 91 industry peers in the Food Products industry. MDLZ has an excellent profitability rating, but there are some minor concerns on its financial health. MDLZ has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year MDLZ was profitable.
MDLZ had a positive operating cash flow in the past year.
In the past 5 years MDLZ has always been profitable.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.29%, MDLZ is in the better half of the industry, outperforming 66.28% of the companies in the same industry.
MDLZ has a Return On Equity of 13.70%. This is in the better half of the industry: MDLZ outperforms 69.77% of its industry peers.
MDLZ's Return On Invested Capital of 8.68% is fine compared to the rest of the industry. MDLZ outperforms 77.91% of its industry peers.
MDLZ had an Average Return On Invested Capital over the past 3 years of 6.55%. This is below the industry average of 9.02%.
The last Return On Invested Capital (8.68%) for MDLZ is above the 3 year average (6.55%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.29% | ||
| ROE | 13.7% | ||
| ROIC | 8.68% |
ROA(3y)5.72%
ROA(5y)5.7%
ROE(3y)14.27%
ROE(5y)14.03%
ROIC(3y)6.55%
ROIC(5y)6.31%
1.3 Margins
MDLZ's Profit Margin of 10.56% is amongst the best of the industry. MDLZ outperforms 86.05% of its industry peers.
In the last couple of years the Profit Margin of MDLZ has remained more or less at the same level.
MDLZ has a better Operating Margin (17.18%) than 90.70% of its industry peers.
In the last couple of years the Operating Margin of MDLZ has remained more or less at the same level.
Looking at the Gross Margin, with a value of 38.77%, MDLZ belongs to the top of the industry, outperforming 90.70% of the companies in the same industry.
MDLZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.18% | ||
| PM (TTM) | 10.56% | ||
| GM | 38.77% |
OM growth 3Y0.4%
OM growth 5Y0.42%
PM growth 3Y0.97%
PM growth 5Y1.49%
GM growth 3Y-0.93%
GM growth 5Y-0.86%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
Compared to 1 year ago, MDLZ has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.38 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ's Altman-Z score of 2.38 is in line compared to the rest of the industry. MDLZ outperforms 51.16% of its industry peers.
The Debt to FCF ratio of MDLZ is 5.35, which is a neutral value as it means it would take MDLZ, 5.35 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 5.35, MDLZ is doing good in the industry, outperforming 62.79% of the companies in the same industry.
MDLZ has a Debt/Equity ratio of 0.65. This is a neutral value indicating MDLZ is somewhat dependend on debt financing.
MDLZ's Debt to Equity ratio of 0.65 is in line compared to the rest of the industry. MDLZ outperforms 41.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.35 | ||
| Altman-Z | 2.38 |
ROIC/WACC1.13
WACC7.68%
2.3 Liquidity
A Current Ratio of 0.63 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ has a worse Current ratio (0.63) than 87.21% of its industry peers.
MDLZ has a Quick Ratio of 0.63. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.42, MDLZ is doing worse than 81.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.42 |
3. Growth
3.1 Past
MDLZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.75%, which is quite good.
The Earnings Per Share has been growing slightly by 6.38% on average over the past years.
MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 2.13%.
The Revenue has been growing slightly by 6.79% on average over the past years.
EPS 1Y (TTM)13.75%
EPS 3Y8.1%
EPS 5Y6.38%
EPS Q2Q%20.73%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y10.66%
Revenue growth 5Y6.79%
Sales Q2Q%1.94%
3.2 Future
MDLZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.29% yearly.
MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.68% yearly.
EPS Next Y7.5%
EPS Next 2Y2.44%
EPS Next 3Y5.59%
EPS Next 5Y5.29%
Revenue Next Year1.6%
Revenue Next 2Y2.82%
Revenue Next 3Y3.3%
Revenue Next 5Y3.68%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.82 indicates a correct valuation of MDLZ.
Compared to the rest of the industry, the Price/Earnings ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 67.44% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MDLZ to the average of the S&P500 Index (28.29), we can say MDLZ is valued slightly cheaper.
The Price/Forward Earnings ratio is 16.58, which indicates a correct valuation of MDLZ.
69.77% of the companies in the same industry are more expensive than MDLZ, based on the Price/Forward Earnings ratio.
MDLZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.82 | ||
| Fwd PE | 16.58 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDLZ is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.81 | ||
| EV/EBITDA | 12.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDLZ does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)2.11
PEG (5Y)2.48
EPS Next 2Y2.44%
EPS Next 3Y5.59%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 3.24%.
MDLZ's Dividend Yield is a higher than the industry average which is at 3.86.
Compared to an average S&P500 Dividend Yield of 2.28, MDLZ pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.24% |
5.2 History
The dividend of MDLZ is nicely growing with an annual growth rate of 11.47%!
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.47%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
60.30% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP60.3%
EPS Next 2Y2.44%
EPS Next 3Y5.59%
MONDELEZ INTERNATIONAL INC-A
NASDAQ:MDLZ (1/21/2025, 8:13:34 PM)
Premarket: 57.6 0 (0%)57.6
-0.26 (-0.45%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners83.81%
Inst Owner Change-0.1%
Ins Owners0.14%
Ins Owner Change0.14%
Market Cap77.02B
Analysts81.21
Price Target79.81 (38.56%)
Short Float %1.53%
Short Ratio2.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.24% |
Yearly Dividend1.59
Dividend Growth(5Y)11.47%
DP60.3%
Div Incr Years10
Div Non Decr Years10
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.63%
Min EPS beat(2)6.99%
Max EPS beat(2)14.26%
EPS beat(4)4
Avg EPS beat(4)8.06%
Min EPS beat(4)5.03%
Max EPS beat(4)14.26%
EPS beat(8)8
Avg EPS beat(8)6.74%
EPS beat(12)11
Avg EPS beat(12)5.89%
EPS beat(16)12
Avg EPS beat(16)4.79%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)-0.99%
Revenue beat(4)0
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)-0.6%
Revenue beat(8)4
Avg Revenue beat(8)0.42%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.97%
PT rev (1m)-2.3%
PT rev (3m)-1.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.82 | ||
| Fwd PE | 16.58 | ||
| P/S | 2.13 | ||
| P/FCF | 20.81 | ||
| P/OCF | 15.36 | ||
| P/B | 2.77 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.52 |
EPS(TTM)3.64
EY6.32%
EPS(NY)3.47
Fwd EY6.03%
FCF(TTM)2.77
FCFY4.81%
OCF(TTM)3.75
OCFY6.51%
SpS27.04
BVpS20.83
TBVpS-11.5
PEG (NY)2.11
PEG (5Y)2.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.29% | ||
| ROE | 13.7% | ||
| ROCE | 12.15% | ||
| ROIC | 8.68% | ||
| ROICexc | 8.94% | ||
| ROICexgc | 58.15% | ||
| OM | 17.18% | ||
| PM (TTM) | 10.56% | ||
| GM | 38.77% | ||
| FCFM | 10.24% |
ROA(3y)5.72%
ROA(5y)5.7%
ROE(3y)14.27%
ROE(5y)14.03%
ROIC(3y)6.55%
ROIC(5y)6.31%
ROICexc(3y)6.86%
ROICexc(5y)6.61%
ROICexgc(3y)39.94%
ROICexgc(5y)36.4%
ROCE(3y)9.04%
ROCE(5y)8.75%
ROICexcg growth 3Y17.96%
ROICexcg growth 5Y12.82%
ROICexc growth 3Y9.68%
ROICexc growth 5Y5.98%
OM growth 3Y0.4%
OM growth 5Y0.42%
PM growth 3Y0.97%
PM growth 5Y1.49%
GM growth 3Y-0.93%
GM growth 5Y-0.86%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.35 | ||
| Debt/EBITDA | 2.4 | ||
| Cap/Depr | 102.34% | ||
| Cap/Sales | 3.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 66.92% | ||
| Profit Quality | 96.99% | ||
| Current Ratio | 0.63 | ||
| Quick Ratio | 0.42 | ||
| Altman-Z | 2.38 |
F-Score8
WACC7.68%
ROIC/WACC1.13
Cap/Depr(3y)86.69%
Cap/Depr(5y)85.15%
Cap/Sales(3y)3.11%
Cap/Sales(5y)3.23%
Profit Quality(3y)85.66%
Profit Quality(5y)84.32%
High Growth Momentum
Growth
EPS 1Y (TTM)13.75%
EPS 3Y8.1%
EPS 5Y6.38%
EPS Q2Q%20.73%
EPS Next Y7.5%
EPS Next 2Y2.44%
EPS Next 3Y5.59%
EPS Next 5Y5.29%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y10.66%
Revenue growth 5Y6.79%
Sales Q2Q%1.94%
Revenue Next Year1.6%
Revenue Next 2Y2.82%
Revenue Next 3Y3.3%
Revenue Next 5Y3.68%
EBIT growth 1Y14.62%
EBIT growth 3Y11.1%
EBIT growth 5Y7.23%
EBIT Next Year27.93%
EBIT Next 3Y10.69%
EBIT Next 5Y9.13%
FCF growth 1Y23.78%
FCF growth 3Y5.12%
FCF growth 5Y4.77%
OCF growth 1Y27.38%
OCF growth 3Y5.95%
OCF growth 5Y3.61%